Henry Schein to sell hematology systems

|About: Henry Schein, Inc. (HSIC)|By:, SA News Editor

Medical products distributor Henry Schein (HSIC) inks a 3-year distribution deal with Sysmex to sell its line of hematology analyzers in the alternate care setting.

Consensus estimates for Q1 and 2014 are EPS of $1.13 on revenues of $2.43B and EPS of $5.37 on revenues of $10.2B, respectively.

780 mutual funds have positions in the stock.